ResearcherMayo Clinic in FloridaActive in the last 2 years
Dominic E. Sanford
Matched on ORCID iD 0000-0001-9487-1621; OpenAlex author ID A5049964541, A5081196508. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 9
- Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery. Co-author DOI 10.1016/j.prro.2026.03.015↗
- Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer. Co-author DOI 10.1126/sciadv.aei1190↗
- Area deprivation and rurality impact overall survival and adjuvant therapy administration in patients with pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1016/j.hpb.2023.08.005↗
- Minimally Invasive Approaches to Pancreatic Cancer. First author DOI 10.1016/j.soc.2018.11.006↗
- Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic du… Co-author DOI 10.1136/gutjnl-2017-313738↗
- Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancrea… Co-author DOI 10.1016/s1470-2045(16)00078-4↗
- Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. First author DOI 10.1007/s00262-014-1527-x↗
- Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Co-author DOI 10.1158/1078-0432.ccr-13-0525↗
- A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.4236/jct.2013.43096↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roheena Z. Panni · 7 shared papers, 2013–2026 · strength 0.65
- Paper Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery. DOI 10.1016/j.prro.2026.03.015↗
- Paper Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancr… DOI 10.1126/sciadv.aei1190↗
- Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
- William G. Hawkins · 5 shared papers, 2013–2026 · strength 0.54
- Paper Area deprivation and rurality impact overall survival and adjuvant therapy administration in patients with pancreatic d… DOI 10.1016/j.hpb.2023.08.005↗
- Paper Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancr… DOI 10.1126/sciadv.aei1190↗
- Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
- Kian‐Huat Lim · 3 shared papers, 2016–2026 · strength 0.49
- Paper Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery. DOI 10.1016/j.prro.2026.03.015↗
- Paper Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancr… DOI 10.1126/sciadv.aei1190↗
- Paper Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline… DOI 10.1016/s1470-2045(16)00078-4↗
- David G DeNardo · 6 shared papers, 2013–2026 · strength 0.46
- Paper Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery. DOI 10.1016/j.prro.2026.03.015↗
- Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
- Paper Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline… DOI 10.1016/s1470-2045(16)00078-4↗
- Carl DeSelm · 2 shared papers, 2026 · strength 0.44
- Paper Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery. DOI 10.1016/j.prro.2026.03.015↗
- Paper Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancr… DOI 10.1126/sciadv.aei1190↗
- Ryan C Fields · 4 shared papers, 2013–2023 · strength 0.35
- Paper Area deprivation and rurality impact overall survival and adjuvant therapy administration in patients with pancreatic d… DOI 10.1016/j.hpb.2023.08.005↗
- Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
- Paper Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline… DOI 10.1016/s1470-2045(16)00078-4↗
- Andrea Wang‐Gillam · 5 shared papers, 2013–2026 · strength 0.34
- Paper Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancr… DOI 10.1126/sciadv.aei1190↗
- Paper Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline… DOI 10.1016/s1470-2045(16)00078-4↗
- Paper Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properti… DOI 10.1007/s00262-014-1527-x↗
- William E. Gillanders · 2 shared papers, 2018–2026 · strength 0.26
- Paper Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancr… DOI 10.1126/sciadv.aei1190↗
- Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
- Patrick M. Grierson · 1 shared paper, 2026 · strength 0.25
- David S. Lakomy · 1 shared paper, 2026 · strength 0.25
- Richard Tsai · 1 shared paper, 2026 · strength 0.25
- Hyun Jee Kim · 1 shared paper, 2026 · strength 0.25
- David C. Linehan · 5 shared papers, 2013–2018 · strength 0.21
- Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
- Paper Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline… DOI 10.1016/s1470-2045(16)00078-4↗
- Paper Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properti… DOI 10.1007/s00262-014-1527-x↗
- Vikram S. Pothuri · 1 shared paper, 2023 · strength 0.20
- Felicia Zhang Perkins · 1 shared paper, 2026 · strength 0.19
- Feng Gao · 1 shared paper, 2026 · strength 0.19
- Elizabeth M. Jaffee · 1 shared paper, 2026 · strength 0.19
- Daniel A. Laheru · 1 shared paper, 2026 · strength 0.19
- Joseph R. Broucek · 1 shared paper, 2019 · strength 0.14
- John Andrew Stauffer · 1 shared paper, 2019 · strength 0.14
- Horacio J. Asbun · 1 shared paper, 2019 · strength 0.14
- Timothy M. Nywening · 2 shared papers, 2016–2018 · strength 0.11
- Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
- Paper Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline… DOI 10.1016/s1470-2045(16)00078-4↗
- Steven M. Strasberg · 2 shared papers, 2013–2016 · strength 0.07
- Paper Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline… DOI 10.1016/s1470-2045(16)00078-4↗
- Paper A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenoca… DOI 10.4236/jct.2013.43096↗
- Booyeon Julia Han · 1 shared paper, 2018 · strength 0.07
- Peter S. Goedegebuure · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.